NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $635,000 | +6.7% | 27,439 | -17.7% | 0.27% | -0.4% |
| Q1 2020 | $595,000 | -17.4% | 33,339 | 0.0% | 0.27% | +9.8% |
| Q4 2019 | $720,000 | +15.8% | 33,339 | -2.3% | 0.24% | +7.0% |
| Q3 2019 | $622,000 | -51.9% | 34,139 | -6.2% | 0.23% | -50.3% |
| Q2 2019 | $1,294,000 | +399.6% | 36,377 | +236.7% | 0.46% | +1019.5% |
| Q3 2017 | $259,000 | -74.9% | 10,804 | -79.6% | 0.04% | -73.4% |
| Q2 2017 | $1,033,000 | +77.8% | 52,856 | +11.7% | 0.15% | +94.9% |
| Q4 2016 | $581,000 | -47.6% | 47,337 | -51.5% | 0.08% | -62.9% |
| Q4 2013 | $1,108,000 | +33.3% | 97,584 | +22.7% | 0.21% | +17.0% |
| Q3 2013 | $831,000 | +13.5% | 79,548 | +25.6% | 0.18% | +6.4% |
| Q2 2013 | $732,000 | – | 63,348 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |